Skip to content

13F-HR filed by Tamarack Capital Management, LLC

Tamarack Capital Management, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-10, with 32 holding rows worth $840,099,000.

Accession
0001095449-15-000149
Filed
2015-11-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 33 entries on the cover page, a total value of $840,099,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $840,102,000 with VALUE read as thousands by filing date, 13F file number 028-15086. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS700,000$134,141,000thousands by filing datecall
ISHARES TR46428743220 YR TR BD ETF762,000$94,137,000thousands by filing datecall
iShares Russell 2000 ETF464287655SHS600,000$65,520,000thousands by filing dateput
PATTERSON COS INC703395103COM1,225,000$52,981,000thousands by filing date
ENDOLOGIX INC29266S106COM4,050,000$49,653,000thousands by filing date
Medtronic PlcG5960L103COM700,000$46,858,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock700,000$43,029,000thousands by filing date
GREATBATCH INC39153L106COM700,000$39,494,000thousands by filing date
BECTON DICKINSON & CO075887109COM275,000$36,482,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK2,000,000$31,540,000thousands by filing date
VERADIGM INC01988P108COMMON STOCK2,150,000$26,660,000thousands by filing date
IMPRIVATA INC45323J103Cmn1,425,000$25,322,000thousands by filing date
ALKERMES PLCG01767105SHS365,000$21,415,000thousands by filing date
Merck & Co.,Inc.58933Y105COM400,000$19,756,000thousands by filing datecall
ATRICURE INC04963C209COM825,000$18,076,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK950,000$16,065,000thousands by filing date
BIO RAD LABS INC090572207CL A110,000$14,774,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock80,000$12,582,000thousands by filing datecall
CORIUM INTL INC21887L107COM1,325,000$12,389,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR200,000$11,292,000thousands by filing datecall
RTI BIOLOGICS INC74975N105COM1,950,000$11,076,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW5,700,000$11,001,000thousands by filing date
Amgen Inc.031162100COM75,000$10,374,000thousands by filing date
SPECTRANETICS CORP84760C107COM785,000$9,255,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock50,000$7,864,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS375,000$5,063,000thousands by filing date
CERUS CORP157085101COM900,000$4,086,000thousands by filing date
LANTHEUS HLDGS INC516544103COM615,000$2,645,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM1,138,000$2,606,000thousands by filing date
HERON THERAPEUTICS INC427746102COM75,000$1,830,000thousands by filing date
NUVASIVE INC670704105COM25,000$1,206,000thousands by filing date
GLOBUS MED INC CL A379577208Stock45,000$930,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001095449-15-000149this filing2015-11-10acceptance time not in the bulk data set